New Zealand markets open in 4 hours 7 minutes

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
66.85+0.04 (+0.06%)
As of 01:53PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 196.06B
Enterprise value 221.33B
Trailing P/E N/A
Forward P/E 18.94
PEG ratio (5-yr expected) 1.41
Price/sales (ttm)4.63
Price/book (mrq)5.50
Enterprise value/revenue 5.33
Enterprise value/EBITDA 31.48

Trading information

Stock price history

Beta (5Y monthly) 0.12
52-week change 317.44%
S&P500 52-week change 3-5.29%
52-week high 371.70
52-week low 353.63
50-day moving average 366.02
200-day moving average 360.52

Share statistics

Avg vol (3-month) 37.3M
Avg vol (10-day) 36.55M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 83.09B
% held by insiders 10.06%
% held by institutions 117.71%
Shares short (12 May 2022) 416.42M
Short ratio (12 May 2022) 42.19
Short % of float (12 May 2022) 4N/A
Short % of shares outstanding (12 May 2022) 40.53%
Shares short (prior month 13 Apr 2022) 410.82M

Dividends & splits

Forward annual dividend rate 41.44
Forward annual dividend yield 42.15%
Trailing annual dividend rate 32.87
Trailing annual dividend yield 34.30%
5-year average dividend yield 43.19
Payout ratio 4N/A
Dividend date 327 Mar 2022
Ex-dividend date 423 Feb 2022
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -2.56%
Operating margin (ttm)15.15%

Management effectiveness

Return on assets (ttm)4.76%
Return on equity (ttm)-4.17%

Income statement

Revenue (ttm)41.49B
Revenue per share (ttm)14.04
Quarterly revenue growth (yoy)55.60%
Gross profit (ttm)27.61B
Net income avi to common (ttm)-1.06B
Diluted EPS (ttm)-0.36
Quarterly earnings growth (yoy)-75.30%

Balance sheet

Total cash (mrq)5.82B
Total cash per share (mrq)1.88
Total debt (mrq)32.75B
Total debt/equity (mrq)90.06
Current ratio (mrq)1.00
Book value per share (mrq)11.74

Cash flow statement

Operating cash flow (ttm)7.26B
Levered free cash flow (ttm)2.63B